Raltegravir Switch for Toxicity or Adverse Events

NCT00958100 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Catholic University of the Sacred Heart